Literature DB >> 22825327

Gadd45a inhibits cell migration and invasion by altering the global RNA expression.

Zhanhai Shan1, Guiyuan Li, Qimin Zhan, Dan Li.   

Abstract

Gadd45a, the first well-defined p53 downstream gene, can be induced by multiple DNA-damaging agents, which plays important roles in the control of cell cycle checkpoint, DNA repair process and signaling transduction. Our previous findings suggested that Gadd45a maintains cell-cell adhesion and cell contact inhibition. However, little is known about how Gadd45a participates in the suppression of malignancy in human cancer cells. To examine the functions of Gadd45a in cell invasion and metastasis, we performed the adhesion, wound-healing and transwell assays in Gadd45a (+/+) and Gadd45a (-/-) MEF cell lines. We found the adhesion, migration and invasive abilities were much higher in Gadd45a deficient cells. We furthermore applied high-throughput cDNA microarray analysis and bioinformatics analysis to analyze the mechanisms of Gadd45a gene in invasion and metastasis. Compared with the Gadd45a wild type cells, the Gadd45a deficient cells showed a wide range of transcripts alterations. The altered gene pathways were predicted by the MAS software, which indicated focal adhesion,cell communication,ECM-receptor interaction as the three main pathways. Real-time PCR was employed to validate the differentially expressed genes. Interestingly, we figured out that the deregulations of these genes are caused neither by genomic aberrations nor methylation status. These findings provided a novel insight that Gadd45a may involve in tumor progression by regulating related genes expressions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825327      PMCID: PMC3461817          DOI: 10.4161/cbt.21186

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  41 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.

Authors:  Shunqian Jin; Tong Tong; Wenhong Fan; Feiyue Fan; Michael J Antinore; Xiaocheng Zhu; Lucia Mazzacurati; Xianxing Li; Kimberly L Petrik; Baskaran Rajasekaran; Min Wu; Qimin Zhan
Journal:  Oncogene       Date:  2002-12-12       Impact factor: 9.867

3.  Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.

Authors:  Namir J Hassan; A Neil Barclay; Marion H Brown
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

4.  Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis.

Authors:  C C Yen; Y J Chen; J T Chen; J Y Hsia; P M Chen; J H Liu; F S Fan; T J Chiou; W S Wang; C H Lin
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

5.  Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer.

Authors:  Kunihiro Yamasawa; Yoshinori Nio; Ming Dong; Kazushige Yamaguchi; Masayuki Itakura
Journal:  Clin Cancer Res       Date:  2002-08       Impact factor: 12.531

6.  Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.

Authors:  Tetsuo Ito; Yutaka Shimada; Yosuke Hashimoto; Junichi Kaganoi; Takatsugu Kan; Go Watanabe; Yoshinori Murakami; Masayuki Imamura
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

Review 7.  Role of matrix metalloproteinases (MMPs) in colorectal cancer.

Authors:  Stanley Zucker; Jeffrey Vacirca
Journal:  Cancer Metastasis Rev       Date:  2004 Jan-Jun       Impact factor: 9.264

8.  Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation.

Authors:  Jeffrey Hildesheim; Galina I Belova; Stuart D Tyner; Xiwu Zhou; Lilit Vardanian; Albert J Fornace
Journal:  Oncogene       Date:  2004-03-11       Impact factor: 9.867

9.  Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.

Authors:  Changhua Zhou; Ashley M Nitschke; Wei Xiong; Qiang Zhang; Yan Tang; Michael Bloch; Steven Elliott; Yun Zhu; Lindsey Bazzone; David Yu; Christopher B Weldon; Rachel Schiff; John A McLachlan; Barbara S Beckman; Thomas E Wiese; Kenneth P Nephew; Bin Shan; Matthew E Burow; Guangdi Wang
Journal:  Breast Cancer Res       Date:  2008-12-16       Impact factor: 6.466

10.  Invasion and MMP expression profile in desmoid tumours.

Authors:  H Denys; O De Wever; B Nusgens; Y Kong; R Sciot; A-T Le; K Van Dam; A Jadidizadeh; S Tejpar; M Mareel; B Alman; J-J Cassiman
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

View more
  10 in total

1.  Directional migration and transcriptional analysis of oligodendrocyte precursors subjected to stimulation of electrical signal.

Authors:  Yongchao Li; Xinkun Wang; Li Yao
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-12       Impact factor: 4.249

2.  GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.

Authors:  Tongtong Li; Lele Xu; Jinglei Teng; Yunping Ma; Wenzhong Liu; Yan Wang; Xinming Chi; Shujuan Shao; Yan Dong; Qimin Zhan; Xuefeng Liu
Journal:  Dig Dis Sci       Date:  2019-09-27       Impact factor: 3.199

Review 3.  DNA damage response genes and the development of cancer metastasis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

4.  Quantification of read species behavior within whole genome sequencing of cancer genomes for the stratification and visualization of genomic variation.

Authors:  Dror Hibsh; Kenneth H Buetow; Gur Yaari; Sol Efroni
Journal:  Nucleic Acids Res       Date:  2016-01-24       Impact factor: 16.971

5.  Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.

Authors:  Seong-Keun Yoo; Seungbok Lee; Su-Jin Kim; Hyeon-Gun Jee; Byoung-Ae Kim; Hyesun Cho; Young Shin Song; Sun Wook Cho; Jae-Kyung Won; Jong-Yeon Shin; Do Joon Park; Jong-Il Kim; Kyu Eun Lee; Young Joo Park; Jeong-Sun Seo
Journal:  PLoS Genet       Date:  2016-08-05       Impact factor: 5.917

6.  Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.

Authors:  Seungbok Lee; Ha Young Park; So Young Kang; Seok Jin Kim; Jinha Hwang; Seungho Lee; Soo Heon Kwak; Kyong Soo Park; Hae Yong Yoo; Won Seog Kim; Jong-Il Kim; Young Hyeh Ko
Journal:  Oncotarget       Date:  2015-07-10

7.  The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.

Authors:  Maria Wiese; Neele Walther; Christopher Diederichs; Fabian Schill; Sebastian Monecke; Gabriela Salinas; Dominik Sturm; Stefan M Pfister; Ralf Dressel; Steven A Johnsen; Christof M Kramm
Journal:  Oncotarget       Date:  2017-04-18

8.  CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.

Authors:  Yuan-Lin Dong; Syeda M Kabir; Eun-Sook Lee; Deok-Soo Son
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

9.  Comparative transcriptomic profiling of hydrogen peroxide signaling networks in zebrafish and human keratinocytes: Implications toward conservation, migration and wound healing.

Authors:  Thomas S Lisse; Benjamin L King; Sandra Rieger
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

10.  The Curcumin Analog CH-5 Exerts Anticancer Effects in Human Osteosarcoma Cells via Modulation of Transcription Factors p53/Sp1.

Authors:  Felipe Teixeira Lima; Viviane Seba; Gabriel Silva; Guilherme Silva Torrezan; Carlos Roberto Polaquini; Vitor Caressato Pinhanelli; Seung J Baek; Ana Lúcia Fachin; Luis Octavio Regasini; Mozart Marins
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.